EBIT: Income before interest and taxes.
Armata Pharmaceuticals, Inc. (ARMP) had EBIT of $-7.78M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.16M |
|
$-26.68M |
|
-- |
|
$1.16M |
|
$8.94M |
|
$-7.78M |
|
$-18.90M |
|
$-26.68M |
|
$-26.68M |
|
$-26.68M |
|
$-26.68M |
|
$-26.68M |
|
$-26.68M |
|
|
EBIT |
$-7.78M |
$-7.41M |
|
36.23M |
|
36.23M |
|
$-0.74 |
|
$-0.74 |
|
| Balance Sheet Financials | |
$16.93M |
|
$12.56M |
|
$72.59M |
|
$89.52M |
|
$139.95M |
|
$15.24M |
|
$45.15M |
|
$185.10M |
|
$-95.59M |
|
$-99.08M |
|
$-95.59M |
|
36.23M |
|
| Cash Flow Statement Financials | |
$-19.09M |
|
$-0.49M |
|
$24.95M |
|
$14.77M |
|
$20.15M |
|
$5.38M |
|
$1.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.12 |
|
-- |
|
-- |
|
-0.19 |
|
-1.53 |
|
100.00% |
|
-670.92% |
|
-670.92% |
|
-- |
|
-2301.55% |
|
-2301.55% |
|
$-19.58M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.53 |
|
58.94 |
|
27.91% |
|
26.92% |
|
-29.80% |
|
33.20% |
|
$-2.64 |
|
$-0.54 |
|
$-0.53 |
|